Literature DB >> 12052456

Stage-dependent changes in trabecular bone turnover and osteogenic capacity of marrow cells during development of type II collagen-induced arthritis in mice.

S Nishida1, H Tsurukami, A Sakai, T Sakata, S Ikeda, M Tanaka, M Ito, T Nakamura.   

Abstract

Rheumatoid arthritis (RA) is a disease characterized by inflammatory polyarthritis leading to destruction of the joints and reduction in bone mass. However, the relationship between bone mass and turnover is not yet clear in RA patients. To clarify the effect of bone turnover and marrow osteogenic capacity on mass and structure during the development of arthritis, we examined DBA1/J mice for 8 weeks after the first immunization with bovine type II collagen at the age of 9 weeks. Localized arthritis developed at 4 weeks and advanced arthritis at 6 weeks postimmunization. Urinary deoxypyridinoline levels in arthritic mice were significantly higher at 4 weeks, and levels were maintained thereafter. Their serum osteocalcin levels were significantly reduced compared with controls at 2 and 6 weeks, but did not differ significantly from those in the control group at 4 and 8 weeks. Three-dimensional (3D) trabecular bone volume of the proximal tibia measured by 3D microcomputed tomography (micro-CT) in the arthritic mice became significantly lower at 4 weeks and decreased further at 6 weeks compared with controls. Parameters of 3D trabecular bone structure, such as structure model index and trabecular bone pattern factor, were increased at 4 and 6 weeks, respectively. Trabecular osteoclast number increased and bone formation rates decreased at 8 weeks. The number of total bone marrow cells (BMCs), adherent stromal cells, and area of mineralized nodule formation in the tibia of arthritic mice were significantly reduced compared with controls at 6 weeks. Numbers of total fibroblastic colony-forming units (CFU-f) and alkaline phosphatase (ALP)-positive CFU-f colonies also decreased. However, the values of these osteogenic parameters corrected for the total BMCs and/or adherent stromal cells did not differ significantly between the arthritic and control groups. These data indicate that an increase in bone resorption led to the reduction in trabecular bone mass and deterioration of 3D structure during the localized arthritic stage. The reduction in bone marrow osteogenic potential in the advanced arthritic stage was due to the reduction in the number of total bone marrow cells, and differentiation of osteogenic cells was apparently unaffected. The reduction in bone formation may not be substantial in this arthritic model.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12052456     DOI: 10.1016/s8756-3282(02)00725-1

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  10 in total

1.  Investigation of microstructural features in regenerating bone using micro computed tomography.

Authors:  A C Jones; A Sakellariou; A Limaye; C H Arns; T J Senden; T Sawkins; M A Knackstedt; D Rohner; D W Hutmacher; A Brandwood; B K Milthorpe
Journal:  J Mater Sci Mater Med       Date:  2004-04       Impact factor: 3.896

2.  Increased chemotaxis and activity of circulatory myeloid progenitor cells may contribute to enhanced osteoclastogenesis and bone loss in the C57BL/6 mouse model of collagen-induced arthritis.

Authors:  M Ikić Matijašević; D Flegar; N Kovačić; V Katavić; T Kelava; A Šućur; S Ivčević; H Cvija; E Lazić Mosler; I Kalajzić; A Marušić; D Grčević
Journal:  Clin Exp Immunol       Date:  2016-10-18       Impact factor: 4.330

3.  Selective cyclooxygenase-2 inhibitor prevents reduction of trabecular bone mass in collagen-induced arthritic mice in association with suppression of RANKL/OPG ratio and IL-6 mRNA expression in synovial tissues but not in bone marrow cells.

Authors:  Tomonori Taketa; Akinori Sakai; Shinya Tanaka; Kenichiro Nakai; Kunitaka Menuki; Hirotoshi Yamane; Kazuhiro Tanaka; Toshitaka Nakamura
Journal:  J Bone Miner Metab       Date:  2008-02-27       Impact factor: 2.626

4.  Protection against Chikungunya virus induced arthralgia following prophylactic treatment with adenovirus vectored interferon (mDEF201).

Authors:  Ashley Dagley; Jane Ennis; Jeffrey D Turner; Kerry A Rood; Arnaud J Van Wettere; Brian B Gowen; Justin G Julander
Journal:  Antiviral Res       Date:  2014-05-14       Impact factor: 5.970

5.  Induction of bone loss in DBA/1J mice immunized with citrullinated autologous mouse type II collagen in the absence of adjuvant.

Authors:  Anand Dusad; Michael J Duryee; Anita T Shaw; Lynell W Klassen; Daniel R Anderson; Dong Wang; Ke Ren; Ellen M Gravallese; James R O'Dell; Ted R Mikuls; Geoffrey M Thiele
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

6.  Organic dust, lipopolysaccharide, and peptidoglycan inhalant exposures result in bone loss/disease.

Authors:  Anand Dusad; Geoff M Thiele; Lynell W Klassen; Angela M Gleason; Christopher Bauer; Ted R Mikuls; Michael J Duryee; William W West; Debra J Romberger; Jill A Poole
Journal:  Am J Respir Cell Mol Biol       Date:  2013-11       Impact factor: 6.914

7.  A multiparameter approach to monitor disease activity in collagen-induced arthritis.

Authors:  Sylvie Seeuws; Peggy Jacques; Jens Van Praet; Michael Drennan; Julie Coudenys; Tine Decruy; Ellen Deschepper; Lien Lepescheux; Philippe Pujuguet; Line Oste; Nick Vandeghinste; Reginald Brys; Gust Verbruggen; Dirk Elewaut
Journal:  Arthritis Res Ther       Date:  2010-08-23       Impact factor: 5.156

8.  Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation.

Authors:  Caroline Jochems; Ulrika Islander; Malin Erlandsson; Margareta Verdrengh; Claes Ohlsson; Hans Carlsten
Journal:  Arthritis Res Ther       Date:  2005-04-27       Impact factor: 5.156

9.  Quantifying not only bone loss, but also soft tissue swelling, in a murine inflammatory arthritis model using micro-computed tomography.

Authors:  E Perilli; M Cantley; V Marino; T N Crotti; M D Smith; D R Haynes; A A S S K Dharmapatni
Journal:  Scand J Immunol       Date:  2015-02       Impact factor: 3.487

10.  Reactivity of rat bone marrow-derived macrophages to neurotransmitter stimulation in the context of collagen II-induced arthritis.

Authors:  Dominique Muschter; Claudia Göttl; Mandy Vogel; Joachim Grifka; Rainer H Straub; Susanne Grässel
Journal:  Arthritis Res Ther       Date:  2015-06-24       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.